📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation. (2016)

First Author: Martin NK

Attributed to: Immunity in the face of diversity and the development of novel potent HCV vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2016.02.007

PubMed Identifier: 26867489

Publication URI: http://europepmc.org/abstract/MED/26867489

Type: Journal Article/Review

Volume: 65

Parent Publication: Journal of hepatology

Issue: 1

ISSN: 0168-8278